Graham David Y, Lee Sun-Young
Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center & Baylor College of Medicine, 2002 Holcombe Boulevard, Houston, TX 77030, USA.
Department of Internal Medicine, Konkuk University School of Medicine, 120-1 Neungdong-ro, Seoul 143-729, Korea.
Gastroenterol Clin North Am. 2015 Sep;44(3):537-63. doi: 10.1016/j.gtc.2015.05.003. Epub 2015 Jun 19.
Bismuth triple therapy was the first effective Helicobacter pylori eradication therapy. The addition of a proton pump inhibitor helped overcome metronidazole resistance. Its primary indication is penicillin allergy or when clarithromycin and metronidazole resistance are both common. Resistance to the primary first-line therapy have centered on complexity and difficulties with compliance. Understanding regional differences in effectiveness remains unexplained because of the lack of studies including susceptibility testing and adherence data. We discuss regimen variations including substitutions of doxycycline, amoxicillin, and twice a day therapy and provide suggestions regarding what is needed to rationally and effectively use bismuth quadruple therapy.
铋剂三联疗法是首个有效的幽门螺杆菌根除疗法。添加质子泵抑制剂有助于克服甲硝唑耐药性。其主要适应证为青霉素过敏或克拉霉素和甲硝唑耐药均常见的情况。对一线初始疗法的耐药性主要集中在复杂性和依从性困难方面。由于缺乏包括药敏试验和依从性数据在内的研究,尚无法解释不同地区疗效差异的原因。我们讨论了包括用多西环素、阿莫西林替代以及每日两次疗法在内的方案差异,并就合理有效使用铋剂四联疗法所需的条件提出了建议。